- Home
- Publications
- Publication Search
- Publication Details
Title
Antibody therapy for Adult T-cell leukemia–lymphoma
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF HEMATOLOGY
Volume 94, Issue 5, Pages 443-452
Publisher
Springer Nature
Online
2011-10-12
DOI
10.1007/s12185-011-0941-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-term study of indolent adult T-cell leukemia-lymphoma
- (2010) Y. Takasaki et al. BLOOD
- Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan
- (2010) M. Iwanaga et al. BLOOD
- Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study
- (2010) M. Hishizawa et al. BLOOD
- Immunopathogenesis of lymphoma: Focus on CCR4
- (2010) Takashi Ishida et al. CANCER SCIENCE
- Defucosylated Humanized Anti-CCR4 Monoclonal Antibody KW-0761 as a Novel Immunotherapeutic Agent for Adult T-cell Leukemia/Lymphoma
- (2010) T. Ishii et al. CLINICAL CANCER RESEARCH
- Is Zidovudine and Interferon-Alfa the Gold Standard for Adult T-Cell Leukemia-Lymphoma?
- (2010) Kenji Ishitsuka et al. JOURNAL OF CLINICAL ONCOLOGY
- Meta-Analysis on the Use of Zidovudine and Interferon-Alfa in Adult T-Cell Leukemia/Lymphoma Showing Improved Survival in the Leukemic Subtypes
- (2010) Ali Bazarbachi et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Study of KW-0761, a Defucosylated Humanized Anti-CCR4 Antibody, in Relapsed Patients With Adult T-Cell Leukemia-Lymphoma and Peripheral T-Cell Lymphoma
- (2010) Kazuhito Yamamoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Brentuximab Vedotin (SGN-35) for Relapsed CD30-Positive Lymphomas
- (2010) Anas Younes et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonfucosylated rituximab potentiates human neutrophil phagocytosis through its high binding for FcγRIIIb and MHC class II expression on the phagocytotic neutrophils
- (2009) Mami Shibata-Koyama et al. EXPERIMENTAL HEMATOLOGY
- Defucosylated Anti-CCR4 Monoclonal Antibody Exerts Potent ADCC against Primary ATLL Cells Mediated by Autologous Human Immune Cells in NOD/Shi-scid, IL-2R null Mice In Vivo
- (2009) A. Ito et al. JOURNAL OF IMMUNOLOGY
- Augmentation of antitumour activity of defucosylated chimeric anti-CCR4 monoclonal antibody in SCID mouse model of adult T-cell leukaemia/lymphoma using G-CSF
- (2008) Hiroki Yano et al. BRITISH JOURNAL OF HAEMATOLOGY
- Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rγnull mouse model
- (2008) Asahi Ito et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1
- (2008) Masaki Ri et al. CANCER SCIENCE
- Definition, Prognostic Factors, Treatment, and Response Criteria of Adult T-Cell Leukemia-Lymphoma: A Proposal From an International Consensus Meeting
- (2008) Kunihiro Tsukasaki et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More